Cyclophosphamide induced early remission and was superior to rituximab in idiopathic membranous nephropathy patients with high anti-PLA2R antibody levels.

Xue, Cheng; Wang, Jian; Pan, Jinyan; Liang, Congdie; Zhou, Chenchen; Wu, Jun; Song, Shuwei; Cui, Linlin; Zhang, Liming; Liu, Yawei; Dai, Bing

Xue, Cheng; Wang, Jian; Pan, Jinyan; Liang, Congdie; Zhou, Chenchen; Wu, Jun; Song, Shuwei; Cui, Linlin; Zhang, Liming; Liu, Yawei; Dai, Bing.

Afiliación

Xue C; Division of Nephrology, Kidney Institute of CPLA, Shanghai Changzheng Hospital, Second Military Medical University (Navy Medical University), xuecheng@smmu.edu.cn, 415 Fengyang Road, Shanghai, 200000, China.
Wang J; Department of Nephrology, No. 2 People's Hospital of Fuyang City, Fuyang, 236000, Anhui Province, China.
Pan J; Department of Outpatient, Jinling Hospital, Nanjing, China.
Liang C; Department of Nephrology, Zhabei Central Hospital of Jing'an District, Shanghai, China.
Zhou C; Division of Nephrology, Kidney Institute of CPLA, Shanghai Changzheng Hospital, Second Military Medical University (Navy Medical University), xuecheng@smmu.edu.cn, 415 Fengyang Road, Shanghai, 200000, China.
Wu J; Outpatient Department, Yangpu Third Military Retreat, Shanghai, China.
Song S; Division of Nephrology, Kidney Institute of CPLA, Shanghai Changzheng Hospital, Second Military Medical University (Navy Medical University), xuecheng@smmu.edu.cn, 415 Fengyang Road, Shanghai, 200000, China.
Cui L; Division of Nephrology, Kidney Institute of CPLA, Shanghai Changzheng Hospital, Second Military Medical University (Navy Medical University), xuecheng@smmu.edu.cn, 415 Fengyang Road, Shanghai, 200000, China.
Zhang L; Division of Nephrology, Kidney Institute of CPLA, Shanghai Changzheng Hospital, Second Military Medical University (Navy Medical University), xuecheng@smmu.edu.cn, 415 Fengyang Road, Shanghai, 200000, China.
Liu Y; Department of Nephrology, Zhabei Central Hospital of Jing'an District, Shanghai, China.
Dai B; Division of Nephrology, Kidney Institute of CPLA, Shanghai Changzheng Hospital, Second Military Medical University (Navy Medical University), xuecheng@smmu.edu.cn, 415 Fengyang Road, Shanghai, 200000, China. lyw1025@163.com.

BMC Nephrol ; 24(1): 280, 2023 09 22.

Article en En | MEDLINE | ID: mdl-37740193

Asunto(s)

Glomerulonefritis Membranosa; Adulto; Humanos; Glomerulonefritis Membranosa/tratamiento farmacológico; Rituximab/uso terapéutico; Ciclofosfamida/uso terapéutico; Pacientes

Palabras clave

Cyclophosphamide; Membranous nephropathy; Meta-analysis; Rituximab; Treatment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glomerulonefritis Membranosa Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies / Systematic_reviews Límite: Adult / Humans Idioma: En Revista: BMC Nephrol Asunto de la revista: NEFROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google